Glaxo Seeks Approval for Tykerb for the Treatment of Advanced Breast Cancer

Armen Hareyan's picture
Advertisement

Breast Cancer Drug Tykerb

GlaxoSmithKline plc today announced the submission of a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for approval to market Tykerb

Advertisement